Rasmus Renstad is an accomplished professional in the field of drug delivery device development, currently serving as Director of Innovation at SHL Medical since June 2013, with previous positions including Vice President Innovation and Director of R&I. Rasmus's extensive experience at SHL Group includes managing research and innovation teams and overseeing medical device development projects. Prior to this, Rasmus held project management roles in drug delivery device R&D at SHL Group AB, and gained experience at Hudson RCI, Cisco Systems, and Nokia. Rasmus holds a B.Sc. in Business Administration & Economics from Stockholm University, a Ph.D. in Polymer Technology, and an M.Sc. in Materials Technology from KTH Royal Institute of Technology.